As part of the Rare Disease Master Class Science & Tech Innovation track from the 2023 RARE Advocacy Summit, this panel will demonstrate how RNA therapies work, why delivery is a critical issue, and efforts to overcome some of the challenges.
RNA Therapies: ASOs, mRNAs, siRNAs
Session Host:
Danny Levine
Life Sciences Writer & RARECast Host, Global Genes
Presenters:
* Chris Hart, PhD
CEO and President, Creyon Bio
* Rachel Groppo, PhD
Director, Replicon Team Lead, Janssen
Stay Connected
Sign up for updates straight to your inbox.